Jayne Prats
Jayne Prats publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine, on topics such as Antiplatelet Therapy and Cardiovascular Diseases, Acute Myocardial Infarction Research and Coronary Interventions and Diagnostics.
- World rank
- #1,438,137 of 7,710,434 ranked researchers
- Rank in United States
- #452,958 of 1,627,098
- Works
- 115
- Citations
- 3.5k
- Citations per work
- 30.8
What does Jayne Prats research?
Jayne Prats's work is mostly in Medicine (82%), Economics, Econometrics and Finance (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences9482.0%
- Medicine9482.0%
- Everything else1916.4%
- Social Sciences21.6%
- 1Cardiology and Cardiovascular Medicine50% of their works
- 2Surgery25% of their works
- 3Internal Medicine4% of their works
- 4Hematology2% of their works
- 5Radiology, Nuclear Medicine and Imaging2% of their works
- 6Economics and Econometrics2% of their works
Research topics
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Coronary Interventions and Diagnostics
- Heparin-Induced Thrombocytopenia and Thrombosis
- Atrial Fibrillation Management and Outcomes
- Venous Thromboembolism Diagnosis and Management
- Lipoproteins and Cardiovascular Health
- Peripheral Artery Disease Management
Which keywords describe Jayne Prats's research?
The keywords of their largest research topics: Percutaneous Coronary Intervention, Aspirin, Clopidogrel, Guidelines, Acute Coronary Syndromes, Myocardial Infarction, Atherosclerosis and Coronary Stents.
- Peripheral Arterial Disease
- Angioplasty
- Antithrombotic Therapy
- Anticoagulant Therapy
- Heparin-Induced Thrombocytopenia
- Diagnosis
- Coronary Stents
- Myocardial Infarction
- Guidelines
- Aspirin
- Percutaneous Coronary Intervention
- Clopidogrel
- Acute Coronary Syndromes
- Atherosclerosis
- Myocardial Revascularization
- Risk Factors
- Thrombosis
- Atrial Fibrillation
- Venous Thromboembolism
- Cholesterol-lowering
- Statins
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Percutaneous Coronary Intervention1152 topics
- Aspirin771 topic
- Clopidogrel771 topic
- Guidelines763 topics
- Acute Coronary Syndromes511 topic
- Myocardial Infarction511 topic
- Atherosclerosis452 topics
- Coronary Stents381 topic
- Myocardial Revascularization381 topic
- Diagnosis322 topics
- Risk Factors202 topics
- Heparin-Induced Thrombocytopenia191 topic
- Thrombosis191 topic
- Anticoagulant Therapy181 topic
- Atrial Fibrillation181 topic
- Antithrombotic Therapy131 topic
- Venous Thromboembolism131 topic
- Angioplasty71 topic
- Cholesterol-lowering71 topic
- Peripheral Arterial Disease71 topic
- Statins71 topic
Where does Jayne Prats work?
Jayne Prats's main affiliation in the publication record is Doctors Company (United States), United States.
How many publications and citations does Jayne Prats have?
OpenAlex counts 115 works and 3,540 citations for Jayne Prats, an h-index of 23, ranking #1,438,137 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jayne Prats. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.